1 SEC 13D/G filing tracked · Last updated Aug 27, 2026
$VRCA - Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Com…